TRAVERE THERAPEUTICS INC (TVTX) Stock Earnings & Estimates
USA - NASDAQ:TVTX - US89422G1076 - Common Stock
25.3 USD
+0.7 (+2.82%)
25.5 USD
+0.2 (+0.79%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 212M -6.81% | 145.238M -31.49% | 233.175M 60.55% | 428.75M 83.87% | 604.5M 40.99% | 807.66M 33.61% | 931.25M 15.30% | 1.206B 29.50% | 1.428B 18.41% | 1.772B 24.09% | 1.989B 12.25% | |
| EBITDA YoY % growth | -233.42M -72.67% | -338.214M -44.90% | -212.629M 37.13% | -88.524M 58.37% | 89.515M 201.12% | 180.01M 101.09% | 502.33M 179.06% | 687.3M 36.82% | 1.108B 61.21% | 1.1B -0.72% | 1.258B 14.36% | |
| EBIT YoY % growth | -266.5M -64.71% | -376.744M -41.37% | -256.184M 32.00% | -94.268M 63.20% | 37.552M 139.84% | 257.78M 586.46% | 290.49M 12.69% | 545.07M 87.64% | 699.26M 28.29% | 882.05M 26.14% | 997.21M 13.06% | |
| Operating Margin | -125.71% | -259.40% | -109.87% | -21.99% | 6.21% | 31.92% | 31.19% | 45.20% | 48.97% | 49.78% | 50.14% | |
| EPS YoY % growth | -4.37 -44.22% | -4.60 -5.26% | -4.10 10.87% | -1.14 72.11% | 0.32 128.28% | 1.86 475.49% | 4.06 118.30% | 5.72 40.87% | 7.67 33.96% | 9.92 29.43% | 11.15 12.41% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.31 55.76% | -0.26 64.94% | -0.08 83.00% | 0.06 140.07% | 0.38 221.85% | 0.53 307.25% |
| Revenue Q2Q % growth | 109.06M 73.39% | 122.01M 63.14% | 119.81M 46.59% | 135.35M 18.26% | 158.63M 45.45% | 180.05M 47.57% |
| EBITDA Q2Q % growth | -10.552M 57.04% | -10.57M 33.01% | 28.387M 195.03% | 41.548M 193.25% | 66.23M 727.66% | 76.989M 828.38% |
| EBIT Q2Q % growth | -22.371M 60.07% | -15.801M 73.37% | -2.744M 93.57% | 10.325M 181.62% | 31.751M 241.93% | 45.49M 387.90% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.14 84.62% | -0.30 | 0.16 | 53.91% |
| Q1 2025 Q2Q % growth | -0.47 73.30% | -0.55 | 0.08 | 14.67% |
| Q4 2024 Q2Q % growth | -0.73 29.13% | -0.57 | -0.16 | -27.29% |
| Q3 2024 Q2Q % growth | -0.70 40.17% | -0.69 | -0.01 | -1.00% |
| Q2 2024 Q2Q % growth | -0.91 19.47% | -0.88 | -0.03 | -3.62% |
| Q1 2024 Q2Q % growth | -1.76 -38.58% | -1.01 | -0.75 | -74.13% |
| Q4 2023 Q2Q % growth | -1.03 | -1.30 | 0.27 | 20.64% |
| Q3 2023 Q2Q % growth | -1.17 -7.34% | -0.15 | -1.02 | -703.66% |
| Q2 2023 Q2Q % growth | -1.13 -7.62% | -1.16 | 0.03 | 2.89% |
| Q1 2023 Q2Q % growth | -1.27 -5.83% | -1.19 | -0.08 | -6.34% |
| Q4 2022 Q2Q % growth | -1.03 -22.62% | -1.10 | 0.07 | 6.02% |
| Q3 2022 Q2Q % growth | -1.09 -84.75% | -0.88 | -0.21 | -23.68% |
| Q2 2022 Q2Q % growth | -1.05 -64.06% | -0.89 | -0.16 | -17.48% |
| Q1 2022 Q2Q % growth | -1.20 -25.00% | -0.87 | -0.33 | -38.18% |
| Q4 2021 Q2Q % growth | -0.84 -75.00% | -0.70 | -0.14 | -20.52% |
| Q3 2021 Q2Q % growth | -0.59 -34.09% | -0.55 | -0.04 | -7.52% |
| Q2 2021 Q2Q % growth | -0.64 -10.34% | -0.70 | 0.06 | 8.18% |
| Q1 2021 Q2Q % growth | -0.96 -4,900.00% | -0.40 | -0.56 | -140.45% |
| Q4 2020 Q2Q % growth | -0.48 31.43% | -0.48 | 0.00 | 0.40% |
| Q3 2020 Q2Q % growth | -0.44 20.00% | -0.53 | 0.09 | 16.35% |
| Q2 2020 Q2Q % growth | -0.58 36.96% | -0.57 | -0.01 | -2.00% |
| Q1 2020 Q2Q % growth | 0.02 102.47% | -0.68 | 0.70 | 102.94% |
| Q4 2019 Q2Q % growth | -0.70 | -0.66 | -0.04 | -6.61% |
| Q3 2019 Q2Q % growth | -0.55 | -1.08 | 0.53 | 48.86% |
| Q2 2019 Q2Q % growth | -0.92 | -0.66 | -0.26 | -40.11% |
| Q1 2019 Q2Q % growth | -0.81 | -0.58 | -0.23 | -38.71% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 114.449M 111.49% | 102.66M | 11.789M | 11.48% |
| Q1 2025 Q2Q % growth | 81.732M 97.54% | 77.043M | 4.689M | 6.09% |
| Q4 2024 Q2Q % growth | 74.787M 65.98% | 74.802M | -15K | -0.02% |
| Q3 2024 Q2Q % growth | 62.898M 69.56% | 61.685M | 1.213M | 1.97% |
| Q2 2024 Q2Q % growth | 54.116M -9.35% | 51.172M | 2.944M | 5.75% |
| Q1 2024 Q2Q % growth | 41.374M -27.41% | 43.704M | -2.33M | -5.33% |
| Q4 2023 Q2Q % growth | 45.059M -19.35% | 42.089M | 2.97M | 7.06% |
| Q3 2023 Q2Q % growth | 37.095M 32.10% | 121.12M | -84.025M | -69.37% |
| Q2 2023 Q2Q % growth | 59.697M 1,576.88% | 54.786M | 4.911M | 8.96% |
| Q1 2023 Q2Q % growth | 56.993M 17.54% | 51.621M | 5.372M | 10.41% |
| Q4 2022 Q2Q % growth | 55.87M -2.41% | 54.075M | 1.795M | 3.32% |
| Q3 2022 Q2Q % growth | 28.08M -58.84% | 55.854M | -27.774M | -49.73% |
| Q2 2022 Q2Q % growth | 3.56M -93.48% | 50.619M | -47.059M | -92.97% |
| Q1 2022 Q2Q % growth | 48.49M 2.28% | 52.957M | -4.467M | -8.44% |
| Q4 2021 Q2Q % growth | 57.25M 12.30% | 58.05M | -800K | -1.38% |
| Q3 2021 Q2Q % growth | 68.22M 33.40% | 62.152M | 6.068M | 9.76% |
| Q2 2021 Q2Q % growth | 54.62M 12.78% | 51.337M | 3.283M | 6.39% |
| Q1 2021 Q2Q % growth | 47.41M -0.75% | 51.089M | -3.679M | -7.20% |
| Q4 2020 Q2Q % growth | 50.98M 9.19% | 52.694M | -1.714M | -3.25% |
| Q3 2020 Q2Q % growth | 51.14M 15.26% | 48.81M | 2.33M | 4.77% |
| Q2 2020 Q2Q % growth | 48.43M 8.32% | 48.015M | 415K | 0.86% |
| Q1 2020 Q2Q % growth | 47.77M 20.72% | 44.296M | 3.474M | 7.84% |
| Q4 2019 Q2Q % growth | 46.69M | 46.941M | -251K | -0.53% |
| Q3 2019 Q2Q % growth | 44.37M | 46.203M | -1.833M | -3.97% |
| Q2 2019 Q2Q % growth | 44.71M | 43.866M | 844K | 1.92% |
| Q1 2019 Q2Q % growth | 39.57M | 41.823M | -2.253M | -5.39% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.73% | -36.47% | 0% | -0.1% |
| Revenue | -0.57% | 6.16% | 0.33% | 5.24% |